Guangzhou Geneseed Biotech. Co.,Ltd., founded in June 2010, is a pioneer in circRNA scientific research and application transformation. Geneseed is firmly grounded in robust and reliable RNA synthesis innovation technology, consistently empowering subdivisions from bench to bedside. Geneseed also broke through the core technological hurdle of circRNA drug and self-developed two RNA circularization strategies --circPrecise? (based on Group I intron self-splicing)& circPure? (based on T4 Rnl2). Relying on our original research and development capability, we have established multiple technology platforms -- gene synthesis, raw material synthesis, high-throughput sequencing, and bioinformatics analysis, which can provide one-stop services covering drug screening, sequence design, process development, analytical method development, large-scale production, quality control, and raw material preparation. Geneseed is committed to providing biopharma with full-process solution CRDMO solution from early R&D to commercial production.
-
2010年
Geneseed Biotech established -
2014年
Committed to circRNA technology research and industrial development to establish a circRNA detection technology platform
-
2015年
Established circRNA in vitro overexpression technology platform
-
2016年
Established circRNA translation technology platform
-
2017年
Established high-throughput sequencing and bioinformatics analysis platform
-
2018年
Established circBank human database platform
-
2019年
Established core tool enzyme development platform
-
2020年
Established circRNA artificial preparation platform
-
2021年
Established circRNA stock solution production platform
-
2022年
Established circRNA process development platform
-
2023年
Established circRNA GMP production platform
2nd Floor, Building A6, Science and Technology Enterprise Accelerator, Guangzhou Development District, No. 11, Kaiyuan Avenue, Guangzhou, China
Copyright：Guangzhou Geneseed Biotech. Co., Ltd. Copyright 2023 All Rights 粵ICP備16055576號(hào)-1